Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Soliton Inc (SOLY)

Soliton Inc (SOLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Soliton Announces Pivotal Cellulite Clinical Trial Results to be Presented at AAD Virtual Meeting June 12-14

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the results from its pivotal...

SOLY : 9.93 (+0.51%)
Soliton Reports First Quarter 2020 Results

, /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the first...

SOLY : 9.93 (+0.51%)
Soliton Announces First Quarter 2020 Financial Results and Business Update on Thursday, May 14, 2020

, May 7, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will report...

SOLY : 9.93 (+0.51%)
Soliton Granted New Key Patent for FDA Cleared RAP Technology

Soliton, Inc. (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Patent and Trademark Office granted the Company's...

SOLY : 9.93 (+0.51%)
Soliton Announces New Launch Plan of Next Generation Acoustic Shockwave Product Due to COVID-19

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today provided an update on its business strategy and financial position...

SOLY : 9.93 (+0.51%)
Soliton to Present Pivotal Cellulite Clinical Trial Results at Virtual AAD 2020 Annual Meeting

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Lead Investigator Evaluates Next-Step for Soliton Pivotal Cellulite Clinical Data

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Receives FDA Clearance of Special 510(k)

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton signs Agreement with Global Manufacturer Sanmina

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SANM : 26.61 (-1.26%)
SOLY : 9.93 (+0.51%)
Soliton to Present Pivotal Cellulite Clinical Trial Results at AAD on March 21, 2020

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Reports Fourth Quarter and Full Year 2019 Results

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Global Medical Device Industry Bolstering Outstanding Growth Potentials

There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future... and most likely beyond then....

SOLY : 9.93 (+0.51%)
MDT : 98.58 (+0.45%)
IVC : 6.16 (-5.52%)
RMTI : 2.14 (unch)
ABT : 94.92 (+3.06%)
Soliton Files Special 510(k) with FDA for its Generation II RAP Device

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Advances Market Launch Preparation; Appoints James Bucher as Senior Sales Consultant

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Appoints Robert "Joe" Mills as Vice President of Supply Chain

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Why the U.S. Remains the Largest Market for Medical Devices

Back in the end of 2018, a report from Moody's said that 2019 should be a standout year for the medical device industry. They added that revenue growth for device companies would be driven through innovation...

SOLY : 9.93 (+0.51%)
ATEC : 4.45 (+1.14%)
MDT : 98.58 (+0.45%)
IMGN : 4.68 (-2.50%)
ACST : 0.6330 (-1.62%)
ACST.VN : 0.870 (unch)
Soliton Announces Successful Completion of Safety Testing at SGS to Support FDA Filing for Second Generation Device

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)
Soliton Appoints Mary Stoll as Senior Director of Clinical Development

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson...

SOLY : 9.93 (+0.51%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.79 , SEDG +6.61 , THC -1.40 , TER +2.46 , LITE +1.03
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar